BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

289 related articles for article (PubMed ID: 17914953)

  • 1. Effects of a novel histamine H2-receptor antagonist, lafutidine, on the mucus barrier of human gastric mucosa.
    Ichikawa T; Ota H; Sugiyama A; Maruta F; Ikezawa T; Hotta K; Ishihara K
    J Gastroenterol Hepatol; 2007 Nov; 22(11):1800-5. PubMed ID: 17914953
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Gastroprotective mechanism of lafutidine, a novel anti-ulcer drug with histamine H2-receptor antagonistic activity.
    Onodera S; Shibata M; Tanaka M; Inaba N; Arai Y; Aoyama M; Lee B; Yamaura T
    Arzneimittelforschung; 1999 Jun; 49(6):519-26. PubMed ID: 10417869
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Lafutidine versus lansoprazole in combination with clarithromycin and amoxicillin for one versus two weeks for Helicobacter pylori eradication in Korea.
    Kim N; Park SH; Seo GS; Lee SW; Kim JW; Lee KJ; Shin WC; Kim TN; Park MI; Park JJ; Hong SJ; Shim KN; Kim SW; Shin YW; Chang YW; Chun HJ; Lee OJ; Jeon WJ; Park CG; Cho CM; Park CH; Won SY; Lee GH; Park KS; Shin JE; Kim HU; Park JY; Chae HS; Song GA; Kim JG; Yoon BC; Seol S; Jung HC; Chung IS
    Helicobacter; 2008 Dec; 13(6):542-9. PubMed ID: 19166420
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Lafutidine prevents low-dose aspirin and loxoprofen induced gastric injury: a randomized, double-blinded, placebo controlled study.
    Kato M; Kamada G; Yamamoto K; Nishida U; Imai A; Yoshida T; Ono S; Nakagawa M; Nakagawa S; Shimizu Y; Asaka M
    J Gastroenterol Hepatol; 2010 Oct; 25(10):1631-5. PubMed ID: 20880171
    [TBL] [Abstract][Full Text] [Related]  

  • 5. [Pharmacological and therapeutic properties of lafutidine (stogar and protecadin), a novel histamine H2 receptor antagonist with gastroprotective activity].
    Tanaka M; Banba M; Joko A; Moriyama Y
    Nihon Yakurigaku Zasshi; 2001 Jun; 117(6):377-86. PubMed ID: 11436515
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Lafutidine can improve the quality of gastric ulcer healing in humans: a randomized, controlled, multicenter trial.
    Higuchi K; Watanabe T; Tominaga K; Shiba M; Nakagawa K; Uno H; Kitada K; Satoh H; Chono S; Oshitani N; Fujiwara Y; Arakawa T
    Inflammopharmacology; 2006 Dec; 14(5-6):226-30. PubMed ID: 17186182
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Effect of Helicobacter pylori status on intragastric pH during administration of lafutidine or famotidine.
    Koike T; Ohara S; Sehine H; Kawamura M; Abe Y; Inomata Y; Iijima K; Imatani A; Shimosegawa T
    Hepatogastroenterology; 2007 Jun; 54(76):1280-4. PubMed ID: 17629089
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Effects of combination treatment with famotidine and methylmethionine sulfonium chloride on the mucus barrier of rat gastric mucosa.
    Ichikawa T; Ito Y; Saegusa Y; Iwai T; Goso Y; Ikezawa T; Ishihara K
    J Gastroenterol Hepatol; 2009 Mar; 24(3):488-92. PubMed ID: 19175830
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Feasibility study of supportive care using lafutidine, a histamine H2 receptor antagonist, to prevent gastrointestinal toxicity during chemotherapy for gastric cancer.
    Namikawa T; Munekage E; Maeda H; Kitagawa H; Kobayashi M; Hanazaki K
    Anticancer Res; 2014 Dec; 34(12):7297-301. PubMed ID: 25503163
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Reversal of the tolerance phenomenon by the intermittent administration of a histamine H2-receptor antagonist.
    Takahashi M; Katayama Y
    J Gastroenterol Hepatol; 2010 Sep; 25(9):1493-7. PubMed ID: 20796145
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Palliative effect of lafutidine on oral burning sensation.
    Toida M; Kato K; Makita H; Long NK; Takeda T; Hatakeyama D; Yamashita T; Shibata T
    J Oral Pathol Med; 2009 Mar; 38(3):262-8. PubMed ID: 19175712
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Protective effect of lafutidine, a histamine H2 receptor antagonist, against loxoprofen-induced small intestinal lesions in rats.
    Amagase K; Ochi A; Sugihara T; Kato S; Takeuchi K
    J Gastroenterol Hepatol; 2010 May; 25 Suppl 1():S111-8. PubMed ID: 20586851
    [TBL] [Abstract][Full Text] [Related]  

  • 13. The histamine H2 receptor antagonist lafutidine in Japanese patients with non-erosive reflux disease.
    Inamori M; Iida H; Hosono K; Endo H; Sakamoto Y; Takahashi H; Koide T; Tokoro C; Goto A; Abe Y; Hiratsuka N; Nakajima A; Fujita M
    Hepatogastroenterology; 2010; 57(104):1430-4. PubMed ID: 21443098
    [TBL] [Abstract][Full Text] [Related]  

  • 14. [A case of paclitaxel-induced peripheral neuropathy successfully treated by H2-blocker, lafutidine].
    Matsumura T; Imamura H; Kishimoto T; Miyazaki Y; Fujii C; Fujino M; Yasui Y; Anami S; Sumita R; Takada N; Fujita Y; Furukawa H
    Gan To Kagaku Ryoho; 2009 Sep; 36(9):1565-8. PubMed ID: 19755835
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Effect of lafutidine, a novel histamine H2-receptor antagonist, on monochloramine-induced gastric lesions in rats: role of capsaicin-sensitive sensory neurons.
    Umeda M; Fujita A; Nishiwaki H; Takeuchi K
    J Gastroenterol Hepatol; 1999 Sep; 14(9):859-65. PubMed ID: 10535466
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Inhibition of neutrophil activation by lafutidine, an H2-receptor antagonist, through enhancement of sensory neuron activation contributes to the reduction of stress-induced gastric mucosal injury in rats.
    Harada N; Okajima K
    Dig Dis Sci; 2007 Feb; 52(2):469-77. PubMed ID: 17211693
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Lafutidine, a unique histamine H2-receptor antagonist, inhibits distention-induced gastric acid secretion through an H2 receptor-independent mechanism.
    Nakano M; Kitano S; Nanri M; Kiniwa M
    Eur J Pharmacol; 2011 May; 658(2-3):236-41. PubMed ID: 21349265
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Lafutidine inhibits Helicobacter pylori-induced interleukin-8 production in human gastric epithelial cells.
    Nozawa Y; Nishihara K; Akizawa Y; Orimoto N; Nakano M; Uji T; Ajioka H; Kanda A; Matsuura N; Kiniwa M
    J Gastroenterol Hepatol; 2004 May; 19(5):506-11. PubMed ID: 15086593
    [TBL] [Abstract][Full Text] [Related]  

  • 19. [Effect of lafutidine, a novel antiulcer agent, on healing and relapse of acetic acid-induced gastric ulcer in rats].
    Onodera S; Tanaka M; Aoyama M; Arai Y; Shibata M; Yamaura T; Ohnishi H
    Nihon Yakurigaku Zasshi; 1998 Mar; 111(3):167-75. PubMed ID: 9583080
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Prophylactic effect of lafutidine against the adverse reaction induced in rat stomach by repeated administration of 5-fluorouracil.
    Kotani T; Nakagiri A; Murashima Y; Takeuchi K
    Inflammopharmacology; 2007 Oct; 15(5):203-8. PubMed ID: 17943252
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 15.